These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19181941)

  • 1. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years.
    O'Sullivan EP; Dinneen SF
    Evid Based Med; 2009 Feb; 14(1):9-10. PubMed ID: 19181941
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years.
    O'Sullivan EP; Dinneen SF
    ACP J Club; 2008 Dec; 149(6):4. PubMed ID: 19071870
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits of early intensive glucose control in preventing diabetes-related complications were sustained for up to 10 years.
    Sherifali D
    Evid Based Nurs; 2009 Jan; 12(1):14. PubMed ID: 19103832
    [No Abstract]   [Full Text] [Related]  

  • 4. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
    Morales A
    J Ark Med Soc; 2009 Oct; 106(4):90-3. PubMed ID: 19813399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus.
    Guo LX; Pan Q; Wang XX; Li H; Zhang LN; Chi JM; Wang Y
    Chin Med J (Engl); 2008 Apr; 121(8):687-90. PubMed ID: 18701019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of an intensive treatment education program for type 1 diabetes in a group of adolescents. A two year follow up].
    Krochik AG; Mazza CS; Araujo MB; Kovalskys I; Ozuna B; Assad D; Coppola L; Domenech I; Lahera E; Zufriategui Z; Gagliardino JJ
    Medicina (B Aires); 2004; 64(2):107-12. PubMed ID: 15628295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal protection in diabetes: role of glycemic control.
    Fioretto P; Bruseghin M; Berto I; Gallina P; Manzato E; Mussap M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S86-9. PubMed ID: 16565255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive therapy for diabetes through influence on innate immune system.
    Li ZZ; Liu JB; Li L; Jiao L; Chen L
    Med Hypotheses; 2009 Jun; 72(6):675-6. PubMed ID: 19264419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G
    J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale for glucose control in diabetes mellitus.
    Nathan DM
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):221-35. PubMed ID: 1612066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
    Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR
    N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
    Ma J; Yang W; Fang N; Zhu W; Wei M
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control.
    Bailey CJ; Del Prato S; Eddy D; Zinman B;
    Int J Clin Pract; 2005 Nov; 59(11):1309-16. PubMed ID: 16236086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
    Akalin S; Berntorp K; Ceriello A; Das AK; Kilpatrick ES; Koblik T; Munichoodappa CS; Pan CY; Rosenthall W; Shestakova M; Wolnik B; Woo V; Yang WY; Yilmaz MT;
    Int J Clin Pract; 2009 Oct; 63(10):1421-5. PubMed ID: 19769698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of sustained moderate weight loss in obesity.
    Pasanisi F; Contaldo F; de Simone G; Mancini M
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.